AEON
AEON Biopharma, Inc. Class A Common Stock (AEON)
$86
About AEON Biopharma, Inc. Class A Common Stock (AEON)
AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Details
Daily high
$0.95
Daily low
$0.82
Price at open
$0.88
52 Week High
$269.28
52 Week Low
$0.38
Market cap
10.3M
Dividend yield
0.00%
Volume
251,439
Avg. volume
2.1M
P/E ratio
.00
AEON Biopharma, Inc. Class A Common Stock News
Details
Daily high
$0.95
Daily low
$0.82
Price at open
$0.88
52 Week High
$269.28
52 Week Low
$0.38
Market cap
10.3M
Dividend yield
0.00%
Volume
251,439
Avg. volume
2.1M
P/E ratio
.00